N-methyladenosine (mA), catalyzed by Mettl3 methyltransferase, is a highly conserved epigenetic modification in eukaryotic messenger RNA (mRNA). Previous studies have implicated mA modification in multiple biological processes, but the function of mA has been difficult to study, because mutants are embryonic lethal in both mammals and plants. In this study, we have used transcription activator-like effector nucleases and generated viable zygotic mutant, Z , in zebrafish. We find that the oocytes in Z adult females are stalled in early development and the ratio of full-grown stage (FG) follicles is significantly lower than that of wild type. Human chorionic gonadotropin-induced ovarian germinal vesicle breakdown and the numbers of eggs ovulated are both decreased as well, while the defects of oocyte maturation can be rescued by sex hormone and In Z adult males, we find defects in sperm maturation and sperm motility is significantly reduced. Further study shows that 11-ketotestosterone (11-KT) and 17β-estradiol (E2) levels are significantly decreased in Z , and defective gamete maturation is accompanied by decreased overall mA modification levels and disrupted expression of genes critical for sex hormone synthesis and gonadotropin signaling in Z Thus, our study provides the first evidence that loss of Mettl3 leads to failed gamete maturation and significantly reduced fertility in zebrafish. Mettl3 and mA modifications are essential for optimal reproduction in vertebrates.

The luteinizing hormone surge is essential for fertility as it triggers ovulation in females and sperm release in males. We previously reported that secretoneurin-a, a neuropeptide derived from the processing of secretogranin-2a (Scg2a), stimulates luteinizing hormone release, suggesting a role in reproduction. Here we provide evidence that mutation of thescg2aandscg2bgenes using TALENs in zebrafish reduces sexual behavior, ovulation, oviposition, and fertility. Large-scale spawning within-line crossings (n= 82 to 101) were conducted. Wild-type (WT) males paired with WT females successfully spawned in 62% of the breeding trials. Spawning success was reduced to 37% (P= 0.006), 44% (P= 0.0169), and 6% (P< 0.0001) forscg2a−/−,scg2b−/−, andscg2a−/−;scg2b−/−mutants, respectively. Comprehensive video analysis indicates thatscg2a−/−;scg2b−/−mutation reduces all male courtship behaviors. Spawning success was 47% in saline-injected WT controls compared to 11% in saline-injectedscg2a−/−;scg2b−/−double mutants. For these mutants, spawning success increased 3-fold following a single intraperitoneal (i.p.) injection of synthetic secretoneurin-a (P= 0.0403) and increased 3.5-fold with injection of human chorionic gonadotropin (hCG). Embryonic survival at 24 h remained on average lower inscg2a−/−;scg2b−/−fish compared to WT injected with secretoneurin-a (P< 0.001). Significant reductions in the expression of gonadotropin-releasing hormone 3 in the hypothalamus, and luteinizing hormone beta and glycoprotein alpha subunits in the pituitary provide evidence for disrupted hypothalamo-pituitary function inscg2aandscg2bmutant fish. Our results indicate that secretogranin-2 is required for optimal reproductive function and support the hypothesis that secretoneurin is a reproductive hormone.